modul 2 kegemukan
TRANSCRIPT
-
7/21/2019 Modul 2 Kegemukan
1/29
MODUL 2 KEGEMUKAN
KELOMPOK 3
-
7/21/2019 Modul 2 Kegemukan
2/29
Kelompok 3
AN RAS FAJRUL IKHSAN
MUH. ILYAS NURDIN
AR RASFIDARIANDI NANDA
AMANDA DYNA FARADILLAH ANDI ASWINY PUTRI BASO
HIBAH MUSLIHAT
NURUL EKAWATY AIS
IRMAWANTI SRI WAHYUNI SAHIR
SHERLY SUMARTIYA
SRI RAHAYU ARISMAWATI NINGSIH
-
7/21/2019 Modul 2 Kegemukan
3/29
Ske!"#$o
Seo#"!% p#$" &m '' (")&! *"("!% ke *ok(e#&!(&k peme#$k+""! ke+e)"("! #&($!. D"#$"!"m!e+$+ *$ke(")&$ ,")-" $,& *"#$ p#$" (e#+e,&(me!*e#$(" *$",e(e+. I" ($*"k me#okok. Peme#$k+""!
+$k TB /01 m BB 45 k% LP 67 m TD /71867mmH%. Peme#$k+""! +$k l"$! *"l"m ,"("+ !o#m"l.
Se(el") *$pe#$k+" l",o#"(o#$&m *$*"p"(k"! )"+$l+,,9
GDP //1 m%8*l kol (o("l 251 m%8*l LDL kol /51m%8*l HDL kol 32 m%8*l "+"m "( 6 m%8*l l"$!:l"$! *"l"m ,"("+ !o#m"l.
-
7/21/2019 Modul 2 Kegemukan
4/29
A!"l$+$+ )"+$l peme#$k+""!
-
7/21/2019 Modul 2 Kegemukan
5/29
D"#$ +ke!"#$o ;
IMT
IMT < BB8=TB>m?
< 458=/0>? < 458270
< 31'0 k%8m? =O,e+ 2>
-
7/21/2019 Modul 2 Kegemukan
6/29
KLASIFIKASI TOTAL, LDL, HDL-KOLESTEROL, DAN TRIGLISERID MENURUTNCEP ATP III
JAMA 2001;285:24862-4!
LDL kolesterol< 100 mg/dl100 129 mg/dl130 159 mg/dl160 189 mg/dl> 190 mg/dl
Total kolesterol< 200 mg/dl200 239 mg/dl> 240 mg/dl
HDL kolesterol< 40 mg/dl> 60 mg/dl
Optmal!e"dekat optmal#edkt t"gg $%orderl"e&T"gg#a"gat t"gg
D"g"ka"#edkt t"gg $%orderl"e&T"gg
'e"da(T"gg
-
7/21/2019 Modul 2 Kegemukan
7/29
TRIGLISERIDA "NCEP-ATP III#
O$%&'() * 150 '+)
S.&/&% %&++&"3.3)&.# 150 - 1'+)
T&++& 200 - 4
'+)
S(+(% %&++& 500 '+)
-
7/21/2019 Modul 2 Kegemukan
8/29
kl"+$k"+$ o,e+$("+ ,e#*. IMT *"! l$!%k"# pe#&(me!&( k#$(e#$" A+$" P"+$k
K)(&/(& IMT "/+'2#
R&&/ /-'3&&%(
L$!%k"# pe#&(@ 61 m =l"k$:l"k$>@ 51 m=pe#emp&"!>
61 m =l"k$:l"k$> 51 m=pe#emp&"!>
Be#"( ,"*"!
k"!%
@/57 Re!*") =#$+$ko
me!$!%k"( p"*"m"+"l") kl$!$+l"$!>
Se*"!%
K$+"#"! !o#m"l /57:226 Se*"!% Me!$!%k"(
Be#"( ,"*"!le,$)
231
: Be#$+$ko 231:2'6 Me!$!%k"( Mo*e#"(WHO WPR8IASO8IOTF *"l"m T)e A+$" P"+$ Pe#+pe($e9Re*e!$!% O,e+$(C "!* $(+ T#e"(me!(
-
7/21/2019 Modul 2 Kegemukan
9/29
-
7/21/2019 Modul 2 Kegemukan
10/29
A!"l$+$+ m"+"l")
-
7/21/2019 Modul 2 Kegemukan
11/29
Pe#("!C""!
B"%"$m"!" me(",ol$+me l$p$* B"%"$m"!" mek"!$+me pe!$!%k"("! ,e#"(
,"*"!
Ho#mo! "p" C"!% ,e#)&,&!%"! *e!%"!
pe!$!%k"("! ,e#"( ,"*"! Ap" e($olo%$ o,e+$("+
A*"k") )&,&!%"! "!("#" %e"l" *e!%"!pe!$!%k"("! ,e#"( ,"*"!8o,e+$("+!C"
Ap" kompl$k"+$ "k$,"( +em&" )"+$lpeme#$k+""! C"!% (el") *$*"p"(k"!
Pe!"("l"k+"!""!
-
7/21/2019 Modul 2 Kegemukan
12/29
Me(",ol$+me l$p$*
-
7/21/2019 Modul 2 Kegemukan
13/29
Mek"!$+me Pe!$!%k"("! ,e#"(
,"*"!
-
7/21/2019 Modul 2 Kegemukan
14/29
F"k(o# "k(o# C"!% me!Ce,",k"!pe!$!%k"("! ,e#"( ,"*"!
-
7/21/2019 Modul 2 Kegemukan
15/29
O,e+$("+
< pe!$m,&!"! lem"k C"!% ,e#le,$)"!*"l"m (&,&) C"!% *$+e,",k"! ole)pem"+&k"! &ml") m"k"!"! C"!% le,$)
,e+"# *"#$p"*" pem"k"$"!!C" ole)(&,&) +e,"%"$ e!e#%$.
+&m,e# 9 ,&k& ""# +$olo%$ G&C(o! *"! H"ll )"l.556
-
7/21/2019 Modul 2 Kegemukan
16/29
-
7/21/2019 Modul 2 Kegemukan
17/29
Ke+e$m,"!%"! E!e#%$
Pem"+&k"!Pe!%el&"#"!
R"+" l"p"#R"+" ke!C"!%Pe!Ce#"p"!
m"k"!"!
Metabolic Rate
Te#mo%e!e+$+Ak($$("+
-
7/21/2019 Modul 2 Kegemukan
18/29
-
7/21/2019 Modul 2 Kegemukan
19/29
Ho#mo! C"!% ,e#)&,&!%"! *e!%"!pe!$!%k"("! ,e#"( ,"*"!
I!+&l$!
Lep($!
Ko#($+ol G#o-() )o#mo!
G)#el$! )o#mo!
T)C#o$* )o#mo!
-
7/21/2019 Modul 2 Kegemukan
20/29
pe!C"k$( C"!% *$($m,&lk"! o,e+$("+
C(3&7(9)(3 3&/(%3
R.$&3(%3 &.(.
H.(3% &.(.
G()))(.3 &.(.
H3'() (3'()&%&.
H$.393&(.'&(( +9%
S%3/.
D&(.%.
O%.(3%
-
7/21/2019 Modul 2 Kegemukan
21/29
K#$(e#$" *$"%!o+$+ S$!*#om me(",ol$k me!&( WHO=Wo#l* He"l() O#%"!$"($o!> NEP:ATP III *"! IDF
KomponenKriteria diagnosis WHO:
Resistensi insulin plus :
Criteria diagnosis ATP
III : 3 komponen di
bawah ini
I!
Obesitas abdominal/
sentral
Waist to hip ratio :
Laki-laki : > 0,9
Wanita : > 0,85 atau
IM >!0 "#/m
Lin#kar perut :
Laki-laki: $0% &m
Wanita : >88 &m
Lin#kar perut :
Laki-laki: '90 &m
Wanita : '80 &m
(iper-
tri#liseridemia
'$50 m#/dl )' $,* mmol/L+ ' $50 m#/dl )'$,*
mmol/L+
' $50 m#/dl
(ipertensi ' $.0/90 mm(# atau
riaat terapi anti hipertensi1
' $!0/85 mm(#
atau riaat terapi anti
hipertensi1
sistolik ' $!0 mm(#
diastolik ' 85 mm(#
"adar #lukosa darahtin##i
oleransi #lukosa ter#an##u,#lukosa puasa
ter#an##u,resistensi insulin
atau M
' $$0 m#/dl 23 ' $00m#/dl
Mikro-albuminuri 4asio albumin urin dan
kreatinin !0 m#/# atau lau
eksresi albumin %0 m/menit
-
7/21/2019 Modul 2 Kegemukan
22/29
S$!*#om me(",ol$k< kom,$!"+$ "k(o#:"k(o# C"!%
mempe#,e+"# #e+$ko +e+eo#"!% &!(&k(e#ke!" pe!C"k$( "!(&!% *$",e(e+ *"!+(#oke
+&m,e# 9 Ame#$"! He"#( A++o$"($o!
-
7/21/2019 Modul 2 Kegemukan
23/29
K#$(e#$" +$!*#om me(",ol$k
O,e+$("+ +e!(#"l
Re+$+(e!+$ $!+&l$!
D$+l$p$*em$": k"*"# HDL kole+(e#ol me!&!
: k"*"# (#$%l$+e#$*" me!$!%k"(
H$pe#(e!+$
-
7/21/2019 Modul 2 Kegemukan
24/29
O,e+$("+ +e!(#"l
Be#*"+"#k"! +ke!"#$o LP< 67m
L$!%k"# pe#&( me!%%"m,"#k"!"#$!%"! "*$po+" +&,k&("! *"!$+e#"l.
-
7/21/2019 Modul 2 Kegemukan
25/29
K"*"# HDL kole+(e#olme!&!
Pe!&!"! k"*"# kole+(e#ol HDL ole)k"#e!" pe!$!%k"("! k"*"# (#$%l$+e#$*"+e)$!%%" (e#"*$ (#"!+e# (#$%l$+e#$*"
ke HDL.
G"!%%&"! m"+&k"! l$p$* po+(:p#"!*$"l p"*" ko!*$+$ #e+$+(e!+$
$!+&l$! +e)$!%%" (e#"*$ %"!%%&"!p#o*&k+$ Al$pop#o(e$! A:/ ole) )"($C"!% +el"!&(!C" me!%"k$,"(k"!
pe!&!"! kole+(e#ol HDL.
-
7/21/2019 Modul 2 Kegemukan
26/29
H$pe#(e!+$
Re+$+(e!+$ $!+&l$! &%" ,e#pe#"! p"*"p"(o%e!e+$+ )$pe#(e!+$.I!+&l$!
-
7/21/2019 Modul 2 Kegemukan
27/29
-
7/21/2019 Modul 2 Kegemukan
28/29
-
7/21/2019 Modul 2 Kegemukan
29/29
TERIMA KASIH